Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 591

1.

Tumor microenvironment and immunology of ovarian cancer: 12th Biennial Rivkin Center Ovarian Cancer Research Symposium.

Mitra AK, Yang-Hartwich Y.

Int J Gynecol Cancer. 2019 Aug;29(Suppl 2):s12-s15. doi: 10.1136/ijgc-2019-000666.

PMID:
31462543
2.

Atomic structures of an entire contractile injection system in both the extended and contracted states.

Desfosses A, Venugopal H, Joshi T, Felix J, Jessop M, Jeong H, Hyun J, Heymann JB, Hurst MRH, Gutsche I, Mitra AK.

Nat Microbiol. 2019 Aug 5. doi: 10.1038/s41564-019-0530-6. [Epub ahead of print]

PMID:
31384001
3.

Self-Assembling Topical Nanomicellar Formulation to Improve Curcumin Absorption Across Ocular Tissues.

Alshamrani M, Sikder S, Coulibaly F, Mandal A, Pal D, Mitra AK.

AAPS PharmSciTech. 2019 Jul 17;20(7):254. doi: 10.1208/s12249-019-1404-1.

PMID:
31317354
4.

Engineering peroxiredoxin 3 to facilitate control over self-assembly.

Conroy F, Rossi T, Ashmead H, Crowther JM, Mitra AK, Gerrard JA.

Biochem Biophys Res Commun. 2019 Apr 30;512(2):263-268. doi: 10.1016/j.bbrc.2019.03.032. Epub 2019 Mar 15.

PMID:
30885432
5.

Association of HCV Infection with C-Reactive Protein: National Health and Nutrition Examination Survey (NHANES), 2009⁻2010.

Bhuiyan AR, Mitra AK, Ogungbe O, Kabir N.

Diseases. 2019 Feb 24;7(1). pii: E25. doi: 10.3390/diseases7010025.

6.

In vivo measurement of trabecular meshwork stiffness in a corticosteroid-induced ocular hypertensive mouse model.

Li G, Lee C, Agrahari V, Wang K, Navarro I, Sherwood JM, Crews K, Farsiu S, Gonzalez P, Lin CW, Mitra AK, Ethier CR, Stamer WD.

Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1714-1722. doi: 10.1073/pnas.1814889116. Epub 2019 Jan 16.

7.

Multi-Layered Nanomicelles as Self-Assembled Nanocarrier Systems for Ocular Peptide Delivery.

Mandal A, Patel P, Pal D, Mitra AK.

AAPS PharmSciTech. 2019 Jan 9;20(2):66. doi: 10.1208/s12249-018-1267-x.

PMID:
30627825
8.

Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease.

Mandal A, Gote V, Pal D, Ogundele A, Mitra AK.

Pharm Res. 2019 Jan 7;36(2):36. doi: 10.1007/s11095-018-2556-5. Review.

PMID:
30617777
9.

Molecular signatures of multiple myeloma progression through single cell RNA-Seq.

Jang JS, Li Y, Mitra AK, Bi L, Abyzov A, van Wijnen AJ, Baughn LB, Van Ness B, Rajkumar V, Kumar S, Jen J.

Blood Cancer J. 2019 Jan 3;9(1):2. doi: 10.1038/s41408-018-0160-x.

10.

Visualization of biological macromolecules at near-atomic resolution: cryo-electron microscopy comes of age.

Mitra AK.

Acta Crystallogr F Struct Biol Commun. 2019 Jan 1;75(Pt 1):3-11. doi: 10.1107/S2053230X18015133. Epub 2019 Jan 1. Review.

PMID:
30605120
11.

Acta Crystallographica Section F - another home for cryo-electron microscopy contributions.

Mitra AK, van Raaij M.

Acta Crystallogr F Struct Biol Commun. 2019 Jan 1;75(Pt 1):1-2. doi: 10.1107/S2053230X18017806. Epub 2019 Jan 1. No abstract available.

12.

IL-6 mediates platinum-induced enrichment of ovarian cancer stem cells.

Wang Y, Zong X, Mitra S, Mitra AK, Matei D, Nephew KP.

JCI Insight. 2018 Dec 6;3(23). pii: 122360. doi: 10.1172/jci.insight.122360.

13.

Cancer Associated Fibroblasts: Naughty Neighbors That Drive Ovarian Cancer Progression.

Dasari S, Fang Y, Mitra AK.

Cancers (Basel). 2018 Oct 29;10(11). pii: E406. doi: 10.3390/cancers10110406. Review.

14.

Body Condition Scoring for Adult Zebrafish (Danio rerio).

Clark TS, Pandolfo LM, Marshall CM, Mitra AK, Schech JM.

J Am Assoc Lab Anim Sci. 2018 Oct 25. doi: 10.30802/AALAS-JAALAS-18-000045. [Epub ahead of print]

15.

Novel Random Triblock Copolymers for Sustained Delivery of Macromolecules for the Treatment of Ocular Diseases.

Ngatuni MJ, Trinh HM, Pal D, Mitra AK.

AAPS PharmSciTech. 2018 Nov;19(8):3871-3885. doi: 10.1208/s12249-018-1172-3. Epub 2018 Oct 10.

PMID:
30306402
16.

A Proximal Culture Method to Study Paracrine Signaling Between Cells.

Dasari S, Pandhiri T, Haley J, Lenz D, Mitra AK.

J Vis Exp. 2018 Aug 28;(138). doi: 10.3791/58144.

PMID:
30222146
17.

The phase problem for two-dimensional crystals. II. Simulations.

Arnal RD, Zhao Y, Mitra AK, Spence JCH, Millane RP.

Acta Crystallogr A Found Adv. 2018 Sep 1;74(Pt 5):537-544. doi: 10.1107/S2053273318008707. Epub 2018 Sep 1.

PMID:
30182940
18.

Corrigendum to "Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells" [Gyncol. Oncol. 144 (2017) 598-606].

Winterhoff BJ, Maile M, Mitra AK, Sebe A, Bazzaro M, Geller MA, Abrahante JE, Klein M, Hellweg R, Mullany SA, Beckman K, Daniel J, Starr TK.

Gynecol Oncol. 2018 Oct;151(1):182-186. doi: 10.1016/j.ygyno.2018.07.015. Epub 2018 Aug 7. No abstract available.

19.

Factors associated with patients' satisfaction of rubber dam use during root canal treatment.

Maslamani M, Mitra AK.

Indian J Dent Res. 2018 Mar-Apr;29(2):144-149. doi: 10.4103/ijdr.IJDR_291_17.

20.

The relationship between outflow resistance and trabecular meshwork stiffness in mice.

Wang K, Li G, Read AT, Navarro I, Mitra AK, Stamer WD, Sulchek T, Ethier CR.

Sci Rep. 2018 Apr 11;8(1):5848. doi: 10.1038/s41598-018-24165-w.

21.

Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis.

Ladanyi A, Mukherjee A, Kenny HA, Johnson A, Mitra AK, Sundaresan S, Nieman KM, Pascual G, Benitah SA, Montag A, Yamada SD, Abumrad NA, Lengyel E.

Oncogene. 2018 Apr;37(17):2285-2301. doi: 10.1038/s41388-017-0093-z. Epub 2018 Feb 5.

22.

Ocular delivery of proteins and peptides: Challenges and novel formulation approaches.

Mandal A, Pal D, Agrahari V, Trinh HM, Joseph M, Mitra AK.

Adv Drug Deliv Rev. 2018 Feb 15;126:67-95. doi: 10.1016/j.addr.2018.01.008. Epub 2018 Jan 13. Review.

23.

DNA Damage and Apoptosis Induction in Cancer Cells by Chemically Engineered Thiolated Riboflavin Gold Nanoassembly.

Sau A, Sanyal S, Bera K, Sen S, Mitra AK, Pal U, Chakraborty PK, Ganguly S, Satpati B, Das C, Basu S.

ACS Appl Mater Interfaces. 2018 Feb 7;10(5):4582-4589. doi: 10.1021/acsami.7b18837. Epub 2018 Jan 27.

PMID:
29338178
24.

Nanoparticles in thermosensitive gel based composite nanosystem for ocular diseases.

Agrahari V, Patel SP, Dhall N, Aulgur Z, Thukral S, Yang X, Conley R, Mitra AK.

Drug Deliv Transl Res. 2018 Apr;8(2):422-435. doi: 10.1007/s13346-017-0435-y.

25.

ETS1 induction by the microenvironment promotes ovarian cancer metastasis through focal adhesion kinase.

Tomar S, Plotnik JP, Haley J, Scantland J, Dasari S, Sheikh Z, Emerson R, Lenz D, Hollenhorst PC, Mitra AK.

Cancer Lett. 2018 Feb 1;414:190-204. doi: 10.1016/j.canlet.2017.11.012. Epub 2017 Nov 22.

26.

Stoichiometry and mechanistic implications of the MacAB-TolC tripartite efflux pump.

Jo I, Hong S, Lee M, Song S, Kim JS, Mitra AK, Hyun J, Lee K, Ha NC.

Biochem Biophys Res Commun. 2017 Dec 16;494(3-4):668-673. doi: 10.1016/j.bbrc.2017.10.102. Epub 2017 Oct 20.

PMID:
29061301
27.

TORC1 organized in inhibited domains (TOROIDs) regulate TORC1 activity.

Prouteau M, Desfosses A, Sieben C, Bourgoint C, Lydia Mozaffari N, Demurtas D, Mitra AK, Guichard P, Manley S, Loewith R.

Nature. 2017 Oct 12;550(7675):265-269. doi: 10.1038/nature24021. Epub 2017 Oct 4.

28.

Synthetic peptides designed to modulate adiponectin assembly improve obesity-related metabolic disorders.

Hampe L, Xu C, Harris PWR, Chen J, Liu M, Middleditch M, Radjainia M, Wang Y, Mitra AK.

Br J Pharmacol. 2017 Dec;174(23):4478-4492. doi: 10.1111/bph.14050. Epub 2017 Nov 2.

29.

Recent Patents and Emerging Therapeutics on Ocular Inflammation and Allergy.

Agrahari V, Aulgur Z, Thukral S, Dhall N, Conley R, Mitra AK.

Recent Pat Inflamm Allergy Drug Discov. 2017;11(2):92-106. doi: 10.2174/1872213X11666170913150146. Review.

PMID:
28901856
30.

Understanding the metal mediated assembly and hydrogel formation of a β-hairpin peptide.

De Leon-Rodriguez LM, Hemar Y, Mitra AK, Brimble MA.

Biomater Sci. 2017 Sep 26;5(10):1993-1997. doi: 10.1039/c7bm00512a.

PMID:
28853745
31.

Neglected Tropical Diseases: Epidemiology and Global Burden.

Mitra AK, Mawson AR.

Trop Med Infect Dis. 2017 Aug 5;2(3). pii: E36. doi: 10.3390/tropicalmed2030036. Review.

32.

Pentablock copolymer dexamethasone nanoformulations elevate MYOC: in vitro liberation, activity and safety in human trabecular meshwork cells.

Agrahari V, Li G, Agrahari V, Navarro I, Perkumas K, Mandal A, Stamer WD, Mitra AK.

Nanomedicine (Lond). 2017 Aug;12(16):1911-1926. doi: 10.2217/nnm-2017-0140. Epub 2017 Jul 31.

33.

A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in multiple myeloma.

Mitra AK, Harding T, Mukherjee UK, Jang JS, Li Y, HongZheng R, Jen J, Sonneveld P, Kumar S, Kuehl WM, Rajkumar V, Van Ness B.

Blood Cancer J. 2017 Jun 30;7(6):e581. doi: 10.1038/bcj.2017.56.

34.

In vitro assembly of the Rous Sarcoma Virus capsid protein into hexamer tubes at physiological temperature.

Jaballah SA, Bailey GD, Desfosses A, Hyun J, Mitra AK, Kingston RL.

Sci Rep. 2017 Jun 6;7(1):2913. doi: 10.1038/s41598-017-02060-0.

35.

Topical Formulation of Self-Assembled Antiviral Prodrug Nanomicelles for Targeted Retinal Delivery.

Mandal A, Cholkar K, Khurana V, Shah A, Agrahari V, Bisht R, Pal D, Mitra AK.

Mol Pharm. 2017 Jun 5;14(6):2056-2069. doi: 10.1021/acs.molpharmaceut.7b00128. Epub 2017 May 17.

PMID:
28471177
36.

Constrained Photophysics of 5,7-dimethoxy-2,3,4,9-tetrahydro-1H-carbazol-1-one in the Bioenvironment of Serum Albumins: A Spectroscopic Endeavour Supported by Molecular Docking Analysis.

Mitra AK, Sau A, Pal U, Saha C, Basu S.

J Fluoresc. 2017 Jul;27(4):1547-1558. doi: 10.1007/s10895-017-2094-2. Epub 2017 Apr 22.

PMID:
28434063
37.

Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells.

Thompson RM, Dytfeld D, Reyes L, Robinson RM, Smith B, Manevich Y, Jakubowiak A, Komarnicki M, Przybylowicz-Chalecka A, Szczepaniak T, Mitra AK, Van Ness BG, Luczak M, Dolloff NG.

Oncotarget. 2017 May 30;8(22):35863-35876. doi: 10.18632/oncotarget.16262.

38.

A de novo splice site mutation in EHMT1 resulting in Kleefstra syndrome with pharmacogenomics screening and behavior therapy for regressive behaviors.

Mitra AK, Dodge J, Van Ness J, Sokeye I, Van Ness B.

Mol Genet Genomic Med. 2016 Dec 26;5(2):130-140. doi: 10.1002/mgg3.265. eCollection 2017 Mar.

39.

Inner ear targeted drug delivery: what does the future hold?

Agrahari V, Agrahari V, Mitra AK.

Ther Deliv. 2017 Apr;8(4):179-184. doi: 10.4155/tde-2017-0001. No abstract available.

PMID:
28222657
40.

Prolactin Receptor-Mediated Internalization of Imaging Agents Detects Epithelial Ovarian Cancer with Enhanced Sensitivity and Specificity.

Sundaram KM, Zhang Y, Mitra AK, Kouadio JK, Gwin K, Kossiakoff AA, Roman BB, Lengyel E, Piccirilli JA.

Cancer Res. 2017 Apr 1;77(7):1684-1696. doi: 10.1158/0008-5472.CAN-16-1454. Epub 2017 Feb 15.

41.

Clear, Aqueous Topical Drop of Triamcinolone Acetonide.

Trinh HM, Cholkar K, Joseph M, Yang X, Mitra AK.

AAPS PharmSciTech. 2017 Oct;18(7):2466-2478. doi: 10.1208/s12249-017-0714-4. Epub 2017 Feb 9.

PMID:
28185211
42.

Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells.

Winterhoff BJ, Maile M, Mitra AK, Sebe A, Bazzaro M, Geller MA, Abrahante JE, Klein M, Hellweg R, Mullany SA, Beckman K, Daniel J, Starr TK.

Gynecol Oncol. 2017 Mar;144(3):598-606. doi: 10.1016/j.ygyno.2017.01.015. Epub 2017 Jan 19. Erratum in: Gynecol Oncol. 2018 Oct;151(1):182-186.

43.

Structural Model of the Tubular Assembly of the Rous Sarcoma Virus Capsid Protein.

Jeon J, Qiao X, Hung I, Mitra AK, Desfosses A, Huang D, Gor'kov PL, Craven RC, Kingston RL, Gan Z, Zhu F, Chen B.

J Am Chem Soc. 2017 Feb 8;139(5):2006-2013. doi: 10.1021/jacs.6b11939. Epub 2017 Jan 27.

PMID:
28094514
44.

Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.

Mandal A, Bisht R, Rupenthal ID, Mitra AK.

J Control Release. 2017 Feb 28;248:96-116. doi: 10.1016/j.jconrel.2017.01.012. Epub 2017 Jan 11. Review.

45.

Association of Quality of Coronal Filling with the Outcome of Endodontic Treatment: A Follow-up Study.

Maslamani M, Khalaf M, Mitra AK.

Dent J (Basel). 2017 Jan 11;5(1). pii: E5. doi: 10.3390/dj5010005.

46.

How are we improving the delivery to back of the eye? Advances and challenges of novel therapeutic approaches.

Agrahari V, Agrahari V, Mandal A, Pal D, Mitra AK.

Expert Opin Drug Deliv. 2017 Oct;14(10):1145-1162. doi: 10.1080/17425247.2017.1272569. Epub 2016 Dec 28. Review.

PMID:
27967247
47.

A comprehensive insight on ocular pharmacokinetics.

Agrahari V, Mandal A, Agrahari V, Trinh HM, Joseph M, Ray A, Hadji H, Mitra R, Pal D, Mitra AK.

Drug Deliv Transl Res. 2016 Dec;6(6):735-754. Review.

48.

Next generation drug delivery: circulatory cells-mediated nanotherapeutic approaches.

Agrahari V, Agrahari V, Mitra AK.

Expert Opin Drug Deliv. 2017 Mar;14(3):285-289. doi: 10.1080/17425247.2017.1254614. Epub 2016 Nov 22. No abstract available.

PMID:
27791407
49.

Multifunctional thermoresponsive designer peptide hydrogels.

De Leon-Rodriguez LM, Hemar Y, Mo G, Mitra AK, Cornish J, Brimble MA.

Acta Biomater. 2017 Jan 1;47:40-49. doi: 10.1016/j.actbio.2016.10.014. Epub 2016 Oct 12.

PMID:
27744067
50.

Uptake and bioconversion of stereoisomeric dipeptide prodrugs of ganciclovir by nanoparticulate carriers in corneal epithelial cells.

Yang X, Sheng Y, Ray A, Shah SJ, Trinh HM, Pal D, Mitra AK.

Drug Deliv. 2016 Sep;23(7):2532-2540. Epub 2015 Mar 16.

PMID:
25775276

Supplemental Content

Loading ...
Support Center